A phase i study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: An NCIC CTG study

Warren P. Mason, Mary MacNeil, Petr Kavan, Jacob Easaw, David MacDonald, Brian Thiessen, Shweta Urva, Zarnie Lwin, Lynn McIntosh, Elizabeth Eisenhauer

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

35 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'A phase i study of temozolomide and everolimus (RAD001) in patients with newly diagnosed and progressive glioblastoma either receiving or not receiving enzyme-inducing anticonvulsants: An NCIC CTG study'. En conjunto forman una huella única.

Medicine & Life Sciences